Citigroup Inc Cytosorbents Corp Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.76 - $3.22 $1,872 - $3,426	-1,064 Reduced 71.7%	420 $1,000
Q1 2022 May 12, 2022	SELL	$2.88 - $4.23 $26,873 - $39,470	-9,331 Reduced 86.28%	1,484 $5,000
Q4 2021 Feb 10, 2022	BUY	$4.05 - $8.11 $23,773 - $47,605	5,870 Added 118.71%	10,815 $45,000
Q3 2021 Nov 10, 2021	BUY	$7.0 - $9.71 $34,615 - $48,015	4,945 New	4,945 $40,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.